Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03719768

Recruitment Status : Active, not recruiting

First Posted : October 25, 2018

Last Update Posted : April 25, 2022

Sponsor:

Collaborator:

Pfizer

Information provided by (Responsible Party):

H. Lee Moffitt Cancer Center and Research Institute

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	July 19, 2022
Estimated Study Completion Date :	March 1, 2025

To Top